Details for Patent: RE46965
✉ Email this page to a colleague
Which drugs does patent RE46965 protect, and when does it expire?
Patent RE46965 protects HALAVEN and is included in one NDA.
Protection for HALAVEN has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has thirty-eight patent family members in fourteen countries.
Summary for Patent: RE46965
| Title: | Intermediates for the preparation of analogs of Halichondrin B |
| Abstract: | The present invention provides macrocyclic compounds, synthesis of the same and intermediates thereto. Such compounds, and compositions thereof, are useful for treating or preventing proliferative disorders Formula (F-4). ##STR00001## |
| Inventor(s): | Austad; Brian (Tewksbury, MA), Chase; Charles E. (Londonderry, NH), Fang; Francis G. (Andover, MA), Calkins; Trevor (Stoughton, WI), Lewis; Bryan M. (North Brunswick, NJ) |
| Assignee: | Eisai R&D Management Co., Ltd. (Tokyo, JP) |
| Application Number: | 13/924,892 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; |
Drugs Protected by US Patent RE46965
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eisai Inc | HALAVEN | eribulin mesylate | SOLUTION;INTRAVENOUS | 201532-001 | Nov 15, 2010 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: RE46965
| PCT Information | |||
| PCT Filed | June 03, 2005 | PCT Application Number: | PCT/US2005/019669 |
| PCT Publication Date: | December 15, 2005 | PCT Publication Number: | WO2005/118565 |
International Family Members for US Patent RE46965
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2005250487 | ⤷ Try a Trial | |||
| Canada | 2567984 | ⤷ Try a Trial | |||
| Canada | 2822994 | ⤷ Try a Trial | |||
| Canada | 2935786 | ⤷ Try a Trial | |||
| Canada | 3028453 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
